Rolke James sold REVB

April 30, 2026 · Form 4 insider transaction

Rolke James sold 10,115 shares of Revelation Biosciences, Inc. at $1.13 per share, a transaction worth $11.4K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
10,115
Price
$1.13
Total value
$11.4K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateApril 30, 2026
Filing dateMay 1, 2026
Shares owned after214,738
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares sold by the issuer on behalf of the reporting person solely to satisfy required tax withholding obligations arising upon the vesting of restricted stock awards. The transaction was mandatory and the reporting person did not exercise investment discretion with respect to the sale.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.14, inclusive. The reporting person undertakes to provide to Revelation Biosciences, Inc. (REVB), any security holder of REVB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR